Stock Events

BioNexus Gene Lab 

$0.48
16
-$0.02-4.06% Today

Statistics

Day High
-
Day Low
-
52W High
3.87
52W Low
0.31
Volume
37,138
Avg. Volume
123,495
Mkt Cap
8.67M
P/E Ratio
4.27
Dividend Yield
-
Dividend
-

Earnings

30SepConfirmed
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0
0
0.01
0.01
Expected EPS
N/A
Actual EPS
0.0017

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BGLC. It's not an investment recommendation.
Alphabet
68918
GOOGL
Apple
60554
AAPL
Microsoft
56693
MSFT
Amazon
51850
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap18.24B
Illumina provides integrated sequencing and array-based solutions for genetic and genomic analysis, directly competing in the gene sequencing space with BioNexus Gene Lab.
CRISPR Therapeutics
CRSP
Mkt Cap4.63B
CRISPR Therapeutics is involved in gene editing, a direct competitor in the genetic engineering and modification sector, offering alternative or complementary technologies to those of BioNexus Gene Lab.
Intellia Therapeutics
NTLA
Mkt Cap2.42B
Intellia Therapeutics is a leading genome editing company that competes with BioNexus Gene Lab in the development of therapeutics based on gene editing technologies.
Editas Medicine
EDIT
Mkt Cap411.19M
Editas Medicine operates in the CRISPR gene editing space, making it a competitor by offering gene editing technologies and therapies that may overlap with or rival those of BioNexus Gene Lab.
Pacific Biosciences of California
PACB
Mkt Cap452.11M
Pacific Biosciences offers long-read sequencing technologies, competing with BioNexus Gene Lab in the genomic analysis and sequencing market.
Regeneron Pharmaceuticals
REGN
Mkt Cap114.81B
Regeneron Pharmaceuticals is involved in genetic sequencing and the development of medications based on genetic insights, positioning it as a competitor in the genetic research and therapeutic development space.
Vertex Pharmaceuticals
VRTX
Mkt Cap126.85B
Vertex Pharmaceuticals engages in the creation of drugs based on genetic insights, making it a competitor in the field of genetic disease treatment and research.
Teladoc Health
TDOC
Mkt Cap1.54B
Teladoc Health, through its acquisition of Livongo and other initiatives, is expanding into the genetic health advice and telemedicine space, indirectly competing with BioNexus Gene Lab's genetic analysis services.
Guardant Health
GH
Mkt Cap3.76B
Guardant Health specializes in cancer diagnostics through liquid biopsies, competing in the genetic testing market, particularly in the oncology segment.

About

Commercial Services
Miscellaneous Commercial Services
BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
Show more...
CEO
Employees
30
Country
US
ISIN
US0906282076

Listings

XNAS
US
BGLC